Pedro Barata: Meet the Experts of VIRO 2025
The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.
- The congress is free to attend.
- Register via the link.
Co-Chair of VIRO
Co-Chair of VIRO
Spotlight on Pedro Barata
Dr. Pedro Barata is an Associate Professor of Medicine at Case Western Reserve University School of Medicine and serves as Director of the Clinical Genitourinary Medical Oncology Research Program as well as Co-Leader of the Genitourinary Disease Team at University Hospitals Seidman Cancer Center. He is an expert in genitourinary oncology with a focus on optimizing treatment sequencing for advanced renal cell carcinoma.
At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Dr. Barata will present on “Treatment Sequencing After IO/TKI Progression”. His talk will cover:
- Challenges and strategies in sequencing therapies following progression on immunotherapy (IO) and tyrosine kinase inhibitors (TKI).
- Insights into current evidence and clinical decision-making in later-line treatments.
- Emerging therapies and their potential roles in overcoming resistance.
- Approaches to personalized care aimed at improving outcomes for patients with advanced RCC.
Leveraging his extensive clinical and research experience, Dr. Barata emphasizes evidence-based, patient-centered treatment sequencing to optimize therapeutic benefit in complex clinical scenarios.
Global Voices in Renal Oncology (VIRO) 2025
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023